Phaseline

Companies › CSPC Zhongnuo Pharmaceutical (Shijiazhuang)

CSPC Zhongnuo Pharmaceutical (Shijiazhuang): clinical trials, targets and expected readouts

4 active drug programs in 7 registered trials: 3 Phase 1, 2 Phase 2, 2 Phase 3; Other, Metabolic and endocrine; next expected readout Nov 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
SYH2053 Injection–Phase 3Non-familial Hypercholesterolemia and Mixed Hyperlipidemia; Heterozygous Familial Hypercholesterolemia (HeFH)Dec 2027
SYH2070 injection
PCSK9 inhibitor
–Phase 2Mixed Hyperlipidemia; Diagnosed With HoFH; Healthy Subjects (HS)Apr 2027
SYH2061–Phase 1Healthy SubjectsNov 2026
SYH2062 injection–Phase 1Healthy Chinese Volunteers–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06842537SYH2062 injectionPhase 1Healthy Chinese VolunteersOtherDec 2025
NCT07241910SYH2061Phase 1Healthy SubjectsOtherNov 2026
NCT07695597SYH2070 injectionPhase 2Mixed HyperlipidemiaMetabolic and endocrineApr 2027
NCT07591298SYH2070 injectionPhase 2Diagnosed With HoFHMetabolic and endocrineSep 2027
NCT07241923SYH2070 injectionPhase 1Healthy Subjects (HS)OtherNov 2027
NCT07421297SYH2053 InjectionPhase 3Non-familial Hypercholesterolemia and Mixed HyperlipidemiaMetabolic and endocrineDec 2027
NCT07465263SYH2053 InjectionPhase 3Heterozygous Familial Hypercholesterolemia (HeFH)Metabolic and endocrineFeb 2028

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

OPKO Health Beijing QL Biopharmaceutical Energenesis Biomedical BrightGene Bio-Medical Technology Tortugas Neuroscience

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.